Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Journal of the American Chemical Society|January 7, 2022
Tuning Photoenolization-Driven Cycloadditions Using Theory and SpectroscopyJiao Yu J Wang, Mitchell T Blyth, Michael S Sherburn, et al.
ANZ Journal of Surgery|March 10, 2026
Pelvic Exenteration: Oncological and Surgical Outcomes From a Single Tertiary Statewide ServiceElena T Blyth, Michael R Lonne, Kandice B Keogh, et al.
Blood|August 10, 2021
An alternate covalent form of platelet αIIbβ3 integrin that resides in focal adhesions and has altered functionAster E Pijning, Mitchell T Blyth, Michelle L Coote, et al.
Scientific Reports|September 8, 2019
Pharmacological mTOR targeting enhances the antineoplastic effects of selective PI3Kα inhibition in medulloblastomaFrank Eckerdt, Jessica Clymer, Jonathan B Bell, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|October 1, 2021
Redox Isomerization/(3+2) Allenoate Annulation by Auto-Tandem Phosphine CatalysisJeremy T Maddigan-Wyatt, Mitchell T Blyth, Jhi Ametovski, et al.
Oncotarget|January 17, 2019
Antineoplastic effects of selective CDK9 inhibition with atuveciclib on cancer stem-like cells in triple-negative breast cancerDaphne Brisard, Frank Eckerdt, Lindsey A Marsh, et al.
International Journal of Environmental Research and Public Health|March 11, 2023
Meet the Medicines-A Crowdsourced Approach to Collecting and Communicating Information about Essential Medicines OnlineYaela N Golumbic, Kymberley R Scroggie, Ciara R Kenneally, et al.
Organic & Biomolecular Chemistry|March 15, 2021
Simple acyclic molecules containing a single charge-assisted O-H group can recognize anions in acetonitrile : water mixturesRosemary J Goodwin, Mitchell T Blyth, Alfred K K Fung, et al.
Chemical Biology & Drug Design|July 2, 2019
Discovery of novel Mnk inhibitors using mutation-based induced-fit virtual high-throughput screeningRama K Mishra, Matthew R Clutter, Gavin T Blyth, et al.
Oncotarget|September 17, 2015
Pre-clinical evidence of PIM kinase inhibitor activity in BCR-ABL1 unmutated and mutated Philadelphia chromosome-positive (Ph+) leukemiasDany A Curi, Elspeth M Beauchamp, Gavin T Blyth, et al.
Pageof 4